Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

Subjects:

Scores, change in the measures of interest, and <i>p</i>-values for binomial tests of significance in change in scores before and since the pandemic began. by Stacey Giroux (13607651)

Subjects:

Significant cholesterol genes arranged by day. by Katherine M. Peterson (19746455)

“…Tiles represent the genes for each sample day when the P-value is ≤ 0.05. Genes with increased expression are blue; genes with decreased expression are orange; the depth of color reflects the magnitude of the increase or decrease. …”

Correlations of cytokines that significantly change between the pre-infusion and post-infusion blood draws pearson’s correlation between cytokine pairs is indicated by color and si... by Jordan K. Abbott (8934239)

Subjects:

Changes in sRAGE levels in BALF after 120 consecutive days of CS exposure. by Yue He (385239)

Subjects:

Significant changes in WNT signalling transcripts associated with PD. by John M. Haynes (331798)

Statistically-significant cytokine changes between the pre-infusion and post-infusion blood draws plot of the mean (dot) and confidence interval (whiskers) for the coefficients of... by Jordan K. Abbott (8934239)

Subjects:

Increased and decreased proteins. by Diego Iacono (10785756)

TPM1, TPM4, PCP4 and NPY are identified as having significantly increased abundance in the hippocampus after LDR exposure. by Diego Iacono (10785756)

Species richness decreases significantly with increasing percent disturbance. by Catherine L. Cardelús (6429320)

Changes in the distribution of average sleep duration. by Hea Ree Park (10769827)

Subjects:

Proportion of T cells with Treg Phenotype increases from pre-infusion to day 7. by Jordan K. Abbott (8934239)

Subjects:

Changes in sleep habits and sleep-related symptoms. by Hea Ree Park (10769827)

Subjects:

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

List of the proteins that increased or decreased significantly with the progression of liver fibrosis. by Kumiko Shirai (13014884)

“…<p>List of the proteins that increased or decreased significantly with the progression of liver fibrosis.…”

Encapsulation efficiency significantly decreases with increasing starting bacterial concentration. by Kelly C. Freudenberger Catanzaro (6701789)

“…Encapsulation efficiency decreased with increasing starting bacterial concentrations. …”

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Significant changes in taxa at 30 days. by Arnon Gal (3150036)

“…<p>Significant changes in taxa at 30 days.</p>…”